CDNA CareDx Inc

Price (delayed)

$71

Market cap

$3.74B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.18

Enterprise value

$3.42B

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant ...

Highlights
The equity has soared by 84% YoY
CDNA's gross profit has surged by 76% year-on-year and by 16% since the previous quarter
The company's quick ratio has surged by 78% YoY but it fell by 19% QoQ
The debt has grown by 4.5% year-on-year but it has declined by 3.7% since the previous quarter

Key stats

What are the main financial stats of CDNA
Market
Shares outstanding
52.63M
Market cap
$3.74B
Enterprise value
$3.42B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.7
Price to sales (P/S)
14.62
EV/EBIT
N/A
EV/EBITDA
6,573.88
EV/Sales
13.48
Earnings
Revenue
$253.6M
EBIT
-$9.99M
EBITDA
$520,000
Free cash flow
-$19.22M
Per share
EPS
-$0.18
Free cash flow per share
-$0.37
Book value per share
$9.22
Revenue per share
$4.86
TBVPS
$9.25
Balance sheet
Total assets
$557.42M
Total liabilities
$77.57M
Debt
$17.78M
Equity
$479.84M
Working capital
$384.74M
Liquidity
Debt to equity
0.04
Current ratio
7.84
Quick ratio
7.44
Net debt/EBITDA
-611.75
Margins
EBITDA margin
0.2%
Gross margin
68%
Net margin
-3.5%
Operating margin
-4.6%
Efficiency
Return on assets
-2%
Return on equity
-2.4%
Return on invested capital
-10.5%
Return on capital employed
-2%
Return on sales
-3.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDNA stock price

How has the CareDx stock price performed over time
Intraday
-0.11%
1 week
13.38%
1 month
6.75%
1 year
35.96%
YTD
-2%
QTD
12.04%

Financial performance

How have CareDx's revenue and profit performed over time
Revenue
$253.6M
Gross profit
$172.35M
Operating income
-$11.57M
Net income
-$8.95M
Gross margin
68%
Net margin
-3.5%
CDNA's gross profit has surged by 76% year-on-year and by 16% since the previous quarter
CareDx's operating margin has soared by 76% YoY and by 43% from the previous quarter
The net margin has surged by 72% year-on-year and by 43% since the previous quarter
The revenue has soared by 69% YoY and by 15% QoQ

Growth

What is CareDx's growth rate over time

Valuation

What is CareDx stock price valuation
P/E
N/A
P/B
7.7
P/S
14.62
EV/EBIT
N/A
EV/EBITDA
6,573.88
EV/Sales
13.48
CareDx's EPS has soared by 59% YoY and by 38% from the previous quarter
The equity has soared by 84% YoY
The stock's price to book (P/B) is 21% less than its 5-year quarterly average of 9.7 and 17% less than its last 4 quarters average of 9.3
The revenue has soared by 69% YoY and by 15% QoQ
The price to sales (P/S) is 61% more than the 5-year quarterly average of 9.1 but 7% less than the last 4 quarters average of 15.8

Efficiency

How efficient is CareDx business performance
The ROIC has soared by 90% YoY and by 48% QoQ
The ROE has soared by 82% YoY and by 43% from the previous quarter
CDNA's return on assets has surged by 79% year-on-year and by 41% since the previous quarter
CareDx's ROS has soared by 73% YoY and by 42% from the previous quarter

Dividends

What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDNA.

Financial health

How did CareDx financials performed over time
The company's quick ratio has surged by 78% YoY but it fell by 19% QoQ
CDNA's current ratio has soared by 77% year-on-year but it is down by 18% since the previous quarter
The debt is 96% smaller than the equity
The equity has soared by 84% YoY
CareDx's debt to equity has decreased by 43% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.